drugset

drugset / Trial / NCT03928470

Clinical Trial to Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

NCT03928470 ↗

Phase 4 Completed 379 enrolled Chong Kun Dang Pharmaceutical

RandomizedParallel-groupDouble-blindTreatment

Summary

To Evaluate the Efficacy and Safety of EsoDuo Tab. 20/800mg

Timeline

Start: 2019-01-29
Primary completion: 2019-12-20
Completion: 2019-12-20

Publications

Park SH, Lee KN, Lee OY, Choi MG, Kim JH, Sung IK, Jang JY, Park KS, Chun HJ, Kim EY, Lee JK, Jang JS, Kim GH, Hong SJ, Lee YC, Choi SC, Kim HS, Kim TO, Baik GH, Jeon YC. A Randomized, Double-Blind, Active-Control, Noninferiority, Multicenter, Phase 4 Study to Evaluate the Efficacy and Safety of Esomeprazole/Sodium Bicarbonate 20/800 mg in Patients with Nonerosive Gastroesophageal Reflux Disease. Gut Liver. 2023 Mar 15;17(2):226-233. doi: 10.5009/gnl220023. Epub 2022 Jun 22.

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	Esomeprazole	Small molecule	20 mg	—
Subject	sodium bicarbonate	Diagnostic / imaging agent	800 mg	—

Indications